Finally, transcriptome profiling of VHL− 786-O MCTS treated with our drug combination not only confirms our results but also opens perspectives to explore additional mechanisms driving apoptosis in VHL-deficient renal carcinoma cells upon cooperative blockade of CK2 and ATM kinases. Here, VHL is linked to renal carcinoma.